The Cell Therapy Technologies Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Media, Sera, Reagents, Cell Engineering products, Cell Culture Vessels, Cell therapy Equipment, System & Software, Others), By Cell Type (T-Cells, Stem Cells, Others), By Cell Process (Cell Processing, Cell Preservation, Distribution, Handling, Process Monitoring and Quality Control), By End-User (Biopharmaceutical & Biotechnology companies, CRO’s & CMO’s, Research Institutes & Cell Banks).
Cell therapy technologies encompass a wide range of methodologies, tools, and platforms used to develop, manufacture, and administer cell-based therapies for treating diseases and regenerating tissues. In 2024, cell therapy technologies include cell culture systems, cell processing equipment, biomaterials, and delivery systems designed to optimize the production, delivery, and engraftment of therapeutic cells in patients. These technologies support various types of cell-based therapies, including stem cell therapy, immune cell therapy, and engineered cell therapy, aimed at restoring tissue function, modulating immune responses, or targeting specific disease pathways. Cell therapy technologies play a crucial role in overcoming challenges such as cell expansion, quality control, and immunogenicity associated with translating cell-based therapies from the laboratory to the clinic. With advancements in cell engineering, biomanufacturing, and regenerative medicine, cell therapy technologies offer improved scalability, reproducibility, and safety profiles, enabling the development of novel treatments for a wide range of diseases, including cancer, cardiovascular disorders, and neurological conditions. As the field of cell therapy continues to evolve, these technologies hold promise for revolutionizing healthcare by providing innovative and personalized therapeutic solutions for patients with unmet medical needs.
A significant trend in the cell therapy technologies market is the emergence of next-generation gene editing technologies. Traditional cell therapy approaches often involve genetic modification of cells using viral vectors or other methods. However, advancements in gene editing tools such as CRISPR-Cas9 offer precise and efficient methods for modifying cellular genomes, enabling targeted gene insertion, deletion, or modification. These technologies enhance the development of cell therapies by enabling the engineering of cells with desired therapeutic properties, improved safety profiles, and reduced off-target effects. The adoption of next-generation gene editing technologies represents a shift towards more sophisticated and customizable approaches in cell therapy development, shaping the market's evolution.
A key driver fueling the cell therapy technologies market is the increasing investment and clinical trials in cell-based therapies. Cell therapies hold immense promise for treating a wide range of diseases, including cancer, autoimmune disorders, and genetic diseases, offering potential curative or disease-modifying benefits. With growing recognition of their therapeutic potential, there's a surge in investment from pharmaceutical companies, biotechnology firms, and venture capitalists to advance cell therapy research and development. Additionally, the number of clinical trials evaluating cell-based therapies continues to rise, driving the demand for innovative technologies for cell expansion, gene editing, cell sorting, and characterization. As the field of cell therapy advances and more therapies progress towards commercialization, the demand for advanced technologies to support their development and manufacturing escalates, stimulating market growth.
An opportunity within the cell therapy technologies market lies in the development of scalable and closed-system manufacturing platforms. Traditional manufacturing methods for cell therapies often involve manual handling, open manipulation, and batch processing, which can introduce contamination risks, variability, and scalability challenges. Developing scalable and closed-system manufacturing platforms offers several advantages, including enhanced sterility, reproducibility, and scalability for large-scale cell production. These platforms can integrate with automated workflows, bioreactors, and monitoring systems to enable controlled and efficient cell expansion, differentiation, and manufacturing processes. Companies investing in the development of scalable and closed-system manufacturing platforms stand to address the evolving needs of cell therapy manufacturers, contract research organizations, and academic institutions, thereby capturing a significant Market Opportunity in cell therapy technologies.
Cell Engineering products stand out as the fastest-growing segment, driven by advancements in genetic engineering and cellular manipulation techniques. This growth is particularly pronounced in T-Cells and Stem Cells, representing the two primary cell types driving innovation and therapeutic development in cell therapy. The increasing demand for precise cell engineering tools and technologies, along with the growing applications of T-Cells and Stem Cells in regenerative medicine and immunotherapy, fuels the rapid expansion of the Cell Therapy Technologies Market. Additionally, the market's evolution includes developments in media, sera, reagents, cell culture vessels, equipment, software, and other supporting components to facilitate the efficient and effective production of cell-based therapies.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossBecton, Dickinson and Company, Danaher Corp, Lonza Group, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc
By Product
Media, Sera, Reagents
Cell Engineering products
Cell Culture Vessels
Cell therapy Equipment
System & Software
Others
By Cell Type
T-Cells
Stem Cells
Others
By Cell Process
Cell Processing
Cell Preservation
Distribution
Handling
Process Monitoring and Quality Control
By End-User
Biopharmaceutical & Biotechnology companies
CRO’s & CMO’s
Research Institutes & Cell Banks
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Becton, Dickinson and Company
Danaher Corp
Lonza Group
Merck KGaA
Sartorius AG
Thermo Fisher Scientific Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Cell Therapy Technologies Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Cell Therapy Technologies Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Cell Therapy Technologies Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Cell Therapy Technologies Market Size Outlook, $ Million, 2021 to 2030
3.2 Cell Therapy Technologies Market Outlook by Type, $ Million, 2021 to 2030
3.3 Cell Therapy Technologies Market Outlook by Product, $ Million, 2021 to 2030
3.4 Cell Therapy Technologies Market Outlook by Application, $ Million, 2021 to 2030
3.5 Cell Therapy Technologies Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Cell Therapy Technologies Industry
4.2 Key Market Trends in Cell Therapy Technologies Industry
4.3 Potential Opportunities in Cell Therapy Technologies Industry
4.4 Key Challenges in Cell Therapy Technologies Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Cell Therapy Technologies Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Cell Therapy Technologies Market Outlook by Segments
7.1 Cell Therapy Technologies Market Outlook by Segments, $ Million, 2021- 2030
By Product
Media, Sera, Reagents
Cell Engineering products
Cell Culture Vessels
Cell therapy Equipment
System & Software
Others
By Cell Type
T-Cells
Stem Cells
Others
By Cell Process
Cell Processing
Cell Preservation
Distribution
Handling
Process Monitoring and Quality Control
By End-User
Biopharmaceutical & Biotechnology companies
CRO’s & CMO’s
Research Institutes & Cell Banks
8 North America Cell Therapy Technologies Market Analysis and Outlook To 2030
8.1 Introduction to North America Cell Therapy Technologies Markets in 2024
8.2 North America Cell Therapy Technologies Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Cell Therapy Technologies Market size Outlook by Segments, 2021-2030
By Product
Media, Sera, Reagents
Cell Engineering products
Cell Culture Vessels
Cell therapy Equipment
System & Software
Others
By Cell Type
T-Cells
Stem Cells
Others
By Cell Process
Cell Processing
Cell Preservation
Distribution
Handling
Process Monitoring and Quality Control
By End-User
Biopharmaceutical & Biotechnology companies
CRO’s & CMO’s
Research Institutes & Cell Banks
9 Europe Cell Therapy Technologies Market Analysis and Outlook To 2030
9.1 Introduction to Europe Cell Therapy Technologies Markets in 2024
9.2 Europe Cell Therapy Technologies Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Cell Therapy Technologies Market Size Outlook by Segments, 2021-2030
By Product
Media, Sera, Reagents
Cell Engineering products
Cell Culture Vessels
Cell therapy Equipment
System & Software
Others
By Cell Type
T-Cells
Stem Cells
Others
By Cell Process
Cell Processing
Cell Preservation
Distribution
Handling
Process Monitoring and Quality Control
By End-User
Biopharmaceutical & Biotechnology companies
CRO’s & CMO’s
Research Institutes & Cell Banks
10 Asia Pacific Cell Therapy Technologies Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Cell Therapy Technologies Markets in 2024
10.2 Asia Pacific Cell Therapy Technologies Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Cell Therapy Technologies Market size Outlook by Segments, 2021-2030
By Product
Media, Sera, Reagents
Cell Engineering products
Cell Culture Vessels
Cell therapy Equipment
System & Software
Others
By Cell Type
T-Cells
Stem Cells
Others
By Cell Process
Cell Processing
Cell Preservation
Distribution
Handling
Process Monitoring and Quality Control
By End-User
Biopharmaceutical & Biotechnology companies
CRO’s & CMO’s
Research Institutes & Cell Banks
11 South America Cell Therapy Technologies Market Analysis and Outlook To 2030
11.1 Introduction to South America Cell Therapy Technologies Markets in 2024
11.2 South America Cell Therapy Technologies Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Cell Therapy Technologies Market size Outlook by Segments, 2021-2030
By Product
Media, Sera, Reagents
Cell Engineering products
Cell Culture Vessels
Cell therapy Equipment
System & Software
Others
By Cell Type
T-Cells
Stem Cells
Others
By Cell Process
Cell Processing
Cell Preservation
Distribution
Handling
Process Monitoring and Quality Control
By End-User
Biopharmaceutical & Biotechnology companies
CRO’s & CMO’s
Research Institutes & Cell Banks
12 Middle East and Africa Cell Therapy Technologies Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Cell Therapy Technologies Markets in 2024
12.2 Middle East and Africa Cell Therapy Technologies Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Cell Therapy Technologies Market size Outlook by Segments, 2021-2030
By Product
Media, Sera, Reagents
Cell Engineering products
Cell Culture Vessels
Cell therapy Equipment
System & Software
Others
By Cell Type
T-Cells
Stem Cells
Others
By Cell Process
Cell Processing
Cell Preservation
Distribution
Handling
Process Monitoring and Quality Control
By End-User
Biopharmaceutical & Biotechnology companies
CRO’s & CMO’s
Research Institutes & Cell Banks
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Becton, Dickinson and Company
Danaher Corp
Lonza Group
Merck KGaA
Sartorius AG
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Media, Sera, Reagents
Cell Engineering products
Cell Culture Vessels
Cell therapy Equipment
System & Software
Others
By Cell Type
T-Cells
Stem Cells
Others
By Cell Process
Cell Processing
Cell Preservation
Distribution
Handling
Process Monitoring and Quality Control
By End-User
Biopharmaceutical & Biotechnology companies
CRO’s & CMO’s
Research Institutes & Cell Banks
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Cell Therapy Technologies Market is one of the lucrative growth markets, poised to register a 15.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Becton, Dickinson and Company, Danaher Corp, Lonza Group, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume